Dual-targeted liposomes delivering ginsenoside CK attenuate cerebral ischemia-reperfusion injury by suppressing PANoptosis via O-GlcNAcylation of RIPK1/RIPK3.

J Ginseng Res · 2026 · PMC13149903 · PMID 42112134

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Notably, ginsenoside CK treatment showed some reduction in infarct volume, but this reduction was less pronounced and did not reach statistical significance compared to the LP/RTG and LP/RG groups, indicating that the liposomal formulation enhances the protective effects of ginsenoside CK ( Fig. 4 B and C).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.